Articles tagged with Heart Failure
Researchers will investigate the relationship between heart function and aorta stiffness to identify risk factors for heart failure in Hispanics/Latinos, who are disproportionately affected by this condition. The study aims to develop new methods for predicting and preventing heart failure in underrepresented populations.
Cardiac reprogramming converts scar tissue into healthy heart muscle, reducing fibrosis and improving heart function in mice with chronic myocardial infarction. This approach could lead to a new treatment for patients with heart attack and heart failure.
A new study found that extreme temperatures are linked to a higher risk of cardiovascular death, particularly heart failure, which was the leading cause of death globally. The research analyzed data from 32 million cardiovascular deaths in 567 cities across 27 countries between 1979 and 2019.
Researchers from Florida Atlantic University have developed a prototype of a novel wearable device that can continuously monitor physiological parameters associated with heart failure in real-time. The device uses sensors embedded in a lightweight belt to track thoracic impedance, electrocardiogram, heart rate, and motion activity, pro...
A new American Heart Association scientific statement highlights the potential benefits and risks of complementary and alternative therapies for heart failure. The statement advises healthcare professionals to discuss CAM use with patients, monitor medication interactions, and consider pharmacists' consultations.
The prevalence of methamphetamine-associated heart failure is rising worldwide, affecting a wide range of socio-economic and racial groups. Meth users are more likely to develop severe disease, with longer hospital stays and readmissions, compared to non-users.
A new gene therapy approach has been developed to boost the expression of the beta-3 adrenergic receptor in heart cells, improving mitochondrial function and preventing or reversing heart failure in a mouse model of aortic stenosis. This could potentially provide new therapeutic options for patients with this condition.
Researchers at the University of Houston have developed a protocol to reprogram human heart cells into specialized cells that conduct electricity, enabling rhythmic heartbeat and repair diseased hearts. The discovery could lead to improved cardiac function and new pharmacological therapies for heart diseases.
A new study from Mount Sinai Hospital finds a strong association between age-related macular degeneration and severe forms of heart disease, including heart failure, heart attacks, and stroke. The study highlights the importance of increased screening for eye disorders to diagnose undetected heart disease.
Researchers report new findings from a landmark transplant, showing unexpected heart conduction measures that did not contribute to failure. The study suggests genetic modifications made to the pig's heart were not responsible for causing these changes.
A University of Gothenburg study found that severe obesity at age 18 is associated with a three- to fourfold increased risk of developing atrial fibrillation in younger middle age. The study analyzed data from over 1.7 million men in Sweden and found that higher BMI was linked to mortality risk, heart failure, and ischemic stroke.
A recent study by Brigham and Women's Hospital found that dapagliflozin consistently improved outcomes for both men and women with heart failure, regardless of left ventricular ejection fraction. The treatment was safe and well-tolerated in both sexes, suggesting a lack of sex-specific indications for this class of HF therapies.
A new study found that rapid optimization of oral heart failure medications reduced the risk of dying or being readmitted for heart failure within six months after discharge. The STRONG-HF trial enrolled over 1,000 people hospitalized for acute heart failure and showed significant improvement in outcomes with high-intensity care.
A new comprehensive guideline, C-CHANGE, offers 83 actionable recommendations to prevent and treat cardiovascular disease in Canadian adults. The updated resource incorporates new or revised recommendations from 11 guideline groups, addressing key risk factors such as dietary habits, smoking, and physical activity.
Researchers evaluated the safety and efficacy of NTLA-2001 in patients with transthyretin amyloid cardiomyopathy. The results showed significant reductions in circulating TTR protein levels, which were sustained for up to six months after treatment.
Researchers found that two common diuretics, chlorthalidone and hydrochlorothiazide, had no difference in cardiovascular outcomes among study participants. However, those taking chlorthalidone showed a reduced risk of heart disease and death by an average of 27% among patients with a history of heart attack or stroke.
A new study has shown that SGLT-2 inhibitors, a type of diabetes medication, can decrease cardiovascular risk in adults with chronic kidney disease. The meta-analysis included results from 13 major clinical trials and found a 28% lower risk of worsening kidney disease and death from cardiovascular disease.
A randomized study compared the effects of torsemide and furosemide in people with heart failure. The study found that both loop diuretics were effective in reducing death and hospitalization rates, with no significant clinical difference between the two medications.
A new study found that long-term treatment with intravenous iron improved symptoms and reduced recurrent hospitalizations among people with heart failure and iron deficiency. The treatment was associated with a significant benefit on reducing the risk of heart failure hospitalization and cardiovascular death.
A new decision support tool used in emergency departments has been shown to reduce 30-day all-cause death or cardiovascular hospitalization rates by 12% in heart failure patients. The validated tool, developed using data analytics, helps clinicians determine risk categories and inform admission or discharge decisions.
A study published in the Journal of the National Comprehensive Cancer Network found that breast cancer survivorship has doubled among Canadian women, with 2.1% of adult females diagnosed with breast cancer and 86% surviving by 2022. The prevalence varies by age group, with senior women having a higher rate of survival.
Dr. David Kass, a Johns Hopkins professor, has advanced understanding of heart disease and its treatments through pioneering clinical studies and molecular research. His work has led to the development of new therapies for heart failure, obesity, muscular dystrophy, and potentially immunotherapy for cancer.
A recent study published in Nature Communications identified a root cause of chronic heart failure following a heart attack, revealing that iron drives the formation of fatty tissue in the heart. This discovery has the potential to prevent heart failure in nearly half a million people in the US and millions more worldwide.
Researchers tracked participants for almost 30 years and found a link between past exposure to intimate partner violence and future cardiovascular health. The study suggests that intimate partner violence is associated with a higher risk of heart attacks, strokes, and heart failure hospitalizations.
A recent analysis of COVID-19-positive donor heart transplants found no significant differences in transplant outcomes compared to those from non-COVID-19 donors. The study's results suggest that COVID-19-positive hearts may be as safe for transplantation, potentially addressing the shortage of available donor organs.
Dr. Eldrin F. Lewis, a clinician scientist at Stanford University School of Medicine, has been awarded the 2022 Clinical Research Prize by the American Heart Association. His work focuses on improving quality of life and care delivery models for patients with heart failure through point-of-care initiatives.
Dr. Christine E. Seidman, a renowned physician-scientist, has made groundbreaking discoveries in genetics and cardiomyopathy, leading to new pharmacological treatments. Her work has improved our understanding of disease risks and has led to unique targeted therapies.
A new study found that living in a community with easy access to grocery stores and affordable, healthy food is associated with lower heart failure death rates. The research analyzed data from nearly 3,000 counties in the US and found that food insecurity is linked to increased rates of death from heart failure.
A large UK Biobank study found that COVID-19 infection is associated with a heightened risk of poor cardiovascular health and death, particularly among those who require hospital admission. The risk remains elevated for some time after the initial infection.
Researchers from Hokkaido University have identified a link between succinyl-CoA levels and energy metabolism in heart cells affected by chronic heart failure. Supplementation with 5-aminolevulinate acid improved heart function and oxidative phosphorylation capacity in mice with surgically blocked blood supply.
A recent NIH-supported study found that Black adults treated at advanced heart failure centers received potentially life-changing therapies, such as transplants and heart pumps, about half as often as white adults due to racial bias. The researchers also suggest that unconscious bias and overt racism may be driving these disparities.
A recent analysis found that higher BMI in adolescent men is strongly associated with developing early atrial fibrillation, as well as subsequent worse clinical outcomes after diagnosis. Men with higher BMIs had significantly increased risks of mortality, heart failure, and ischemic stroke.
A new study found that a specific genetic mutation can protect the heart from the damaging effects of high blood pressure, unlike in other individuals. The researchers discovered that this mutation leads to overactive phosphodiesterase 3A enzyme production, but unexpectedly does not cause cardiac hypertrophy or heart failure.
Researchers from Indiana University School of Medicine found that many reasons clinicians reject transplantation in cannabis users have no scientific basis. They identified areas where more research is needed, including interactions between cannabis and immunosuppressants.
A study found that in people with significant kidney disease, psoriasis does not increase the risk of heart attack. After controlling for other risk factors, researchers found no association between psoriasis and heart attacks in patients with end-stage renal disease.
A global study found that cardiovascular disease risk factors are largely the same for men and women, except for high LDL levels which affect men more. Women have a lower risk of heart attack and stroke due to their estrogen's effect on vessel walls and liver function.
A new study found that soluble urokinase plasminogen activator receptor (suPAR) levels are significantly higher in patients with heart failure, predicting both heart failure and death. When combined with traditional measures like BNP, suPAR's predictive ability increases.
A national study found that patients with cardiovascular disease had a higher mortality rate than those without, but this association was largely due to shared risk factors. Myocardial injury was common among critically ill COVID-19 patients and associated with poor outcomes.
Children with homozygous familial hypercholesterolemia are diagnosed earlier and have higher untreated LDL-C levels than adults, while those not identified early miss out on decades of life-saving treatment. This study emphasizes the need for universal screening to identify children with HoFH or heterozygous familial hypercholesterolemia.
A team of scientists will lead a Phase III trial to examine whether a novel physical rehabilitation intervention can reduce rehospitalizations and mortality in patients hospitalized for heart failure with preserved ejection fraction (HFpEF). The REHAB-HF program involves strength, balance, endurance, and mobility training exercises tai...
Researchers developed an AI algorithm to assess retinal vasculature, predicting cardiovascular disease and death. The model captured half to two-thirds of circulatory disease deaths in those most at risk, outperforming traditional risk frameworks.
The Leducq Foundation has awarded $7.5 million to UVA researchers, led by Mete Civelek, to investigate sex differences in atherosclerosis and $8 million to Coleen McNamara to advance immunotherapy for cardiovascular disease. These projects aim to improve understanding of heart disease and develop new treatments.
A collaborative home-based palliative care model has been shown to improve health care outcomes for adults with chronic heart failure. The study found that patients who received this care were less likely to die in the hospital and more likely to die at home compared to those who received usual care.
Researchers have identified two NLRP sensors, NLRP1 and CARD8, as key players in Coxsackievirus B3-induced heart inflammation. Targeting CARD8 may prevent CVB3 infections from progressing to heart failure. The study provides new insights into the inflammatory response triggered by this common viral cause of viral myocarditis.
A nationwide study in France found that hot temperatures were closely linked with weight loss in heart failure patients, indicating a worsening of their condition. This association was strong and clinically relevant, prompting recommendations for healthcare professionals to reduce diuretic medication when weight loss occurs.
Researchers at the University of East Anglia have developed a super-fast MRI scan that can diagnose patients with heart failure in record time. The new 4D heart MRI scan takes just eight minutes to produce detailed images of the heart valves and blood flow, helping doctors determine the best course of treatment.
A new study has identified a potential prognostic biomarker for heart failure with preserved ejection fraction (HFpEF), where patients with higher blood levels of endotrophin are at increased risk of adverse outcomes. The finding could lead to the development of a standard blood test to assess HFpEF patients and guide treatment.
The University of Ottawa-led team aims to bridge the gap between heart and brain health by developing new diagnostic tools and treatments. They will focus on improving patient outcomes for disorders linked to both organs.
A new software application predicts the likelihood that a case of dilated cardiomyopathy has a genetic mutation. The Madrid Genotype Score identifies patients most likely to have inherited the disease, facilitating genetic screening and tailored treatment adjustments.
Studies investigate lifestyle interventions to achieve nutritional ketosis and its impact on chronic illness, sleep, and cardiovascular disease in the military. Researchers aim to understand how ketogenic diet, ketone-based beverages, and their effects on clinical outcomes will benefit soldiers' health.
Participation in the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) is associated with improved birth outcomes, including lower infant mortality. The review also found that WIC participants are more likely to receive child preventative services, such as vaccines.
Scientists have discovered three proteins with therapeutic potential to prevent cardiac damage and preserve cardiac function after a heart attack. The proteins, Chrdl1, Fam3c, and Fam3b, were identified through an innovative technology called FunSel that screens human proteins for protective effects.
A new study from the Smidt Heart Institute shows that when height is accounted for, women are 50% more likely to develop atrial fibrillation (AFib) than men. The study's findings suggest that medical practitioners must remain vigilant in promoting AFib prevention and early interventions among both female and male patients.
A new study published in the Journal of the American Heart Association found that low physical function after age 65 is associated with a greater risk of developing heart attack, heart failure, and stroke. The study used the Short Physical Performance Battery (SPPB) test to assess physical function in 5,570 adults over 75 years old.
A study published in Circulation found that moderate or vigorous physical activity can lower the risk of developing heart failure. The research, which analyzed data from over 94,000 adults, suggests that increasing physical activity duration and intensity may provide greater protection against heart failure.
The study found that the probability of surviving cardiac arrest outside hospital has more than doubled in 30 years, from approximately 5% to 11%. The improvement is attributed to increased CPR training and better healthcare resources. However, ambulance delays and an increase in difficult-to-treat cases are hindering further progress.
The TCT MedTech Innovation Forum is an intensive summit bringing together clinicians, entrepreneurs, investors, and regulators to identify clinical challenges and drive innovation in medtech. The agenda features interdisciplinary perspectives on unmet clinical needs, financing, regulatory policy, and evolving healthcare delivery models.
Researchers at Temple University hospital found that maternal-fetal mortality can be reduced to zero through patient-tailored management of right heart function prior to delivery. Women with pulmonary hypertension who received specialized care had excellent outcomes, with 100% survival for mothers and infants.
Symptoms of cardiovascular diseases, including heart attack and heart failure, can profoundly affect quality of life. The American Heart Association scientific statement highlights the importance of tracking symptoms to detect changes and progression.
A new study provides critical insights into the pGC-A membrane receptor, a vital component of cardiovascular regulation. The research offers a clearer understanding of this complex receptor and its signaling mechanisms, paving the way for new anti-hypertensive drugs.